| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |